DossierENTITY

patient backlash

Coverage of patient backlash in the Nexus archive.

Earliest in view: May 28 · 10:45 UTCMost recent: May 28 · 10:45 UTC

Co-mentioned in this coverage

Recent coverage

HEALTHMay 28 · 10:45 UTCNBC NEWS
CVS Caremark will cover Lilly’s weight loss drug Zepbound again after patient backlash
CVS Caremark has resumed coverage of Eli Lilly's weight loss drug Zepbound following patient backlash over its initial decision to stop covering the medication. The reversal highlights patient advocacy influencing healthcare policy.